Cargando…
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients
The prompt rollout of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine is facilitating population immunity, which is becoming more dominant than natural infection-mediated immunity. In the midst of coronavirus disease 2019 (COVID-19) vaccine deployment, understanding the...
Autores principales: | Nitahara, Yuko, Nakagama, Yu, Kaku, Natsuko, Candray, Katherine, Michimuko, Yu, Tshibangu-Kabamba, Evariste, Kaneko, Akira, Yamamoto, Hiromasa, Mizobata, Yasumitsu, Kakeya, Hiroshi, Yasugi, Mayo, Kido, Yasutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579840/ https://www.ncbi.nlm.nih.gov/pubmed/34756082 http://dx.doi.org/10.1128/Spectrum.00965-21 |
Ejemplares similares
-
A Dual-Antigen SARS-CoV-2 Serological Assay Reflects Antibody Avidity
por: Nakagama, Yu, et al.
Publicado: (2022) -
Cumulative seroprevalence among healthcare workers after the first wave of the COVID-19 pandemic in El Salvador, Central America
por: Nakagama, Yu, et al.
Publicado: (2022) -
Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response
por: Nakagama, Sachie, et al.
Publicado: (2023) -
Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies
por: Nakagama, Yu, et al.
Publicado: (2022) -
Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity
por: Nakagama, Yu, et al.
Publicado: (2022)